Cranial Irradiation Can Increase Risk of Pituitary Deficiencies Later in Life, Study Says

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Decades after undergoing cranial irradiation for childhood cancer, researchers at St. Jude Children’s Research Hospital found that adult survivors of pediatric cancer remain at risk for pituitary hormone deficiencies that may diminish their health and quality of life. The study included 748 St. Jude survivors of leukemia, brain and other cancers whose treatment included brain...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

In an effort to target the right patients, genetic screening is becoming more common in clinical trials. But incorporating it can be complex and add a significant burden for both patients and clinical trial sites. Genetic counseling can streamline that process and help drug and gene therapy developers expedite the recruitment of genetically-eligible participants for their trials and use genetic testing results to accelerate the speed and success of clinical trials.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login